World renowned robotic prostate cancer surgeon in New York supports new study for use of ConfirmMDx

/
World renowned robotic prostate cancer surgeon in New York supports new study for use of ConfirmMDx

Dr. David Samadi is a world renowned prostate cancer surgeon and urologic oncologist in New York. He specializes in the treatment of prostate cancer, as well as other prostate conditions such as benign prostatic hyperplasia. Dr. Samadi supports new data from MDxHealth suggesting that the diagnostic test, ConfirmMDx, is useful for helping to diagnose or rule out prostate cancer.

Read More

Imaging technology for prostate cancer

/
Imaging technology for prostate cancer

If you have been diagnosed with prostate cancer, a doctor will combine the results of their digital rectal exam (DRE), prostate-specific antigen (PSA) and Gleason score from their biopsy to determine whether their cancer has a chance of spreading (metastasizing) beyond the prostate gland. The compiled data is then used to determine if an imaging test is required to search for any potential spread of prostate cancer.

Read More

HIFU for prostate cancer

/
HIFU for prostate cancer

What is HIFU? HIFU stands for High Intensity Focused Ultrasound. It delivers high frequency sound waves which creates heat to specific areas of the prostate to kill the cancer cells. A trans-rectal probe is inserted into your rectum to reach the prostate and more accurately target the prostate cancer with the strong beams.

Read More

Prostate Cancer and Erectile Dysfunction

/
Prostate Cancer and Erectile Dysfunction

Erectile dysfunction is the inability to achieve and/or sustain an erection adequate for sexual intercourse. A concern for many men with a diagnosis of prostate cancer is whether or not they will still be as sexually functional as they were prior to having received treatment. It can be both physically and emotionally taxing to cope with.  It’s important to understand that prostate cancer is not the direct cause for erectile dysfunction, although certain treatments for the disease can directly cause the condition. 

Read More

Fewer Men are being screened for Prostate Cancer

/

Two new studies published on Tuesday in The Journal of the American Medical Association highlight that likely in accordance to USPSTF recommendations against screening, fewer men are being screened for prostate cancer and fewer cases of early state prostate cancer are being detected. The question is, if decreased screening is leading to a lower rate of diagnosis, what does this mean for the future of prostate cancer patients? 

Read More

Oncotype DX: New Genetic Test For Prostate Cancer

/
Oncotype DX: New Genetic Test For Prostate Cancer

A new genetic test has recently become available called Oncotype DX. The test is made by Genomic Health and will now be available at Dr. Samadi's Prostate Cancer Center in New York City. What is Oncotype DX? The Oncotype DX prostate cancer test is a biopsy-based genetic test that can be combined with other measures to predict the aggressiveness of prostate cancer. The test applies advanced genomic science to reveal the unique biology of a tumor in order to optimize cancer treatment decisions for each individual patient.

Read More

MRI Fusion Guided Prostate Biopsy

/
MRI Fusion Guided Prostate Biopsy

The MRI fusion guided prostate biopsy “fuses” MRI scans with real-time ultrasound images of the prostate. This cutting-edge biopsy system allows us here at the Dr. David Samadi Prostate Cancer Center to pinpoint specific tumors within the prostate gland. This information provides the patient with the most optimal treatment plan and best possible outcome in detecting and diagnosing prostate cancer.

Read More